|
Volumn 36, Issue 2, 2002, Pages 231-235
|
Experience with an adverse drug reaction reporting program in a neurology specialty clinic
|
Author keywords
Adverse drug reaction; Ambulatory care; Neurology; Outcomes research; Pharmacy practice; Reporting system
|
Indexed keywords
AMITRIPTYLINE;
BETA1A INTERFERON;
CARBAMAZEPINE;
CLONAZEPAM;
COTRIMOXAZOLE;
GABAPENTIN;
LAMOTRIGINE;
MEDROXYPROGESTERONE;
PHENYTOIN;
PROPRANOLOL;
RISPERIDONE;
SELEGILINE;
TACROLIMUS;
TICLOPIDINE;
VALPROIC ACID;
AMBULATORY CARE;
ARTICLE;
CARDIOTOXICITY;
CLINICAL PRACTICE;
DATA ANALYSIS;
DRUG INDUCED DISEASE;
DYSPNEA;
FOLLOW UP;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL TOXICITY;
GINGIVA HYPERPLASIA;
HEALTH CARE QUALITY;
HUMAN;
MEDICAL AUDIT;
NEUROTOXICITY;
OUTCOMES RESEARCH;
PATIENT;
PHARMACEUTICAL CARE;
PHARMACIST;
PHYSICIAN;
PRIORITY JOURNAL;
QUALITY CONTROL;
SKIN MANIFESTATION;
THORAX PAIN;
UNIVERSITY HOSPITAL;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
HOSPITALS, UNIVERSITY;
NEUROLOGY;
OUTPATIENT CLINICS, HOSPITAL;
PERSONNEL, HOSPITAL;
PHARMACEUTICAL PREPARATIONS;
PHARMACY SERVICE, HOSPITAL;
|
EID: 0036161614
PISSN: 10600280
EISSN: None
Source Type: Journal
DOI: 10.1345/aph.1Z430 Document Type: Article |
Times cited : (3)
|
References (14)
|